6 Reasons to Adopt a Low-Code LIMS
Low-code LIMS offer an adaptable, nimble platform, facilitating quick customization to cater to the specific, individualized needs of a lab.
Read More
Search Results for: liver disease
COLA Names Keynote Speakers for Laboratory Enrichment Forum
Industry leaders at COLA will share insights on advancements in lab science and crucial aspects of CLIA compliance and lab accreditation.
Read More
Lung Fibrosis Biomarker Receives FDA De Novo Marketing Authorization
This FDA De Novo marketing authorization signifies the first ever FDA authorization of a diagnostic tool of any type in lung fibrosis.
Read More
Handheld Mole Imaging System Demonstrates Noninvasive Detection of Melanoma Activity
The molecular Skin Fluorescence Imaging System noninvasively identifies and assesses activity associated with melanoma development.
Read More
Veracyte Adds MRD Capabilities to Diagnostics Platform Following C2i Genomics Acquisition
Veracyte will acquire C2i Genomics, a MRD detection company, adding whole-genome MRD capabilities to its diagnostics platform.
Read More